Clinical trial
Growth Hormone, Cardiovascular Risk, and Visceral Adiposity
NCT00131378 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00131378 |
|---|---|
| Title | Growth Hormone, Cardiovascular Risk, and Visceral Adiposity |
| Official title | Growth Hormone, Cardiovascular Risk, and Visceral Adiposity |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | Nutropin AQ growth hormone, Placebo Growth Hormone |
| Enrollment | 142 |
| Start date | Nov 1, 2004 |
| Primary completion | Nov 1, 2012 |
| Completion | Jun 1, 2013 |
| First posted | Aug 18, 2005 |
| Last update posted | Mar 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: